1145P Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab: Analysis of a prospective German MCC registry (MCC TRIM)Jürgen C. Becker, S. Ugurel-Becker, Claudia Pfoehler et al.|Annals of Oncology|2023Cited by 3
EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology GroupSeyed Hamidreza Mahmoudpour, Selma Ugurel, J.C. Backer et al.|Value in Health|2023Cited by 0
Clinical characteristics and survival of patients with advanced Merkel cell carcinoma treated with avelumab: analysis of a prospective German Merkel cell carcinoma registryJürgen Becker, Selma Ugurel, Seyed Hamidreza Mahmoudpour et al.|EJC Skin Cancer|2025Cited by 0
Real-world safety and effectiveness of avelumab in immune-compromised (IC) and non-IC patients with Merkel cell carcinoma (MCC): Results from a prospective German registry (MCC-TRIM)Jürgen Becker, Selma Ugurel, Seyed Hamidreza Mahmoudpour et al.|EJC Skin Cancer|2025Cited by 0
EE509 Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry StudyHamid Mahmoudpour, Dina Oksen, Jürgen C. Becker et al.|Value in Health|2025Cited by 0